Skip to main content
. 2020 Apr 3;10(23):13687–13695. doi: 10.1039/d0ra00897d

Fig. 6. (a) In vivo T1-weighted MRI after intravenous injection with Mn3O4@PEG-GMBP1 NPs at different time points of preinjection, 2, 3, 4 and 6 h. The tumors are indicated by white circles; (b) changes in MR intensity of Mn3O4@PEG-GMBP1 NPs over time in vivo imaging studies.

Fig. 6